Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02352896 · ClinicalTrials.gov registry record · Phase 2
Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome
A Phase 2 study, sponsored by PTC Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT02352896 is a Phase 2 study that has completed, run by PTC Therapeutics. The registered enrollment target is 30 participants.
The verdict
NCT02352896, a Phase 2 study, has completed, sponsored by PTC Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
EPI-743 in Leigh syndrome participants that participated in previous EPI743-12-002 (NCT01721733) study.
Interventions
- DRUG EPI-743
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-01-31 |
| Est. Completion | 2023-10-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02352896
The ClinicalTrials.gov registry entry for NCT02352896 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PTC Therapeutics, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EPI-743 is the first listed.
NCT02352896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02352896 about?
NCT02352896 is a clinical study titled "Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome". EPI-743 in Leigh syndrome participants that participated in previous EPI743-12-002 (NCT01721733) study.
What is the current status of trial NCT02352896?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2014-01-31. Estimated completion is 2023-10-30.
What interventions are being tested in trial NCT02352896?
The interventions under investigation include: EPI-743 (DRUG).
Who is sponsoring clinical trial NCT02352896?
This trial is sponsored by PTC Therapeutics, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.